Related Experiment Video
Updated: Jul 9, 2026
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis
Charles E Patek1, Mark J Arends, William A H Wallace
1Sir Alastair Currie Cancer Research UK Laboratories, Molecular Medicine Centre, The University of Edinburgh, Western General Hospital, Edinburgh, UK.
Experimental Cell Research
|December 8, 2007
Summary
Mutationally activated K-ras 4A promotes lung tumor growth, while wild-type K-ras 4B reduces tumor size. Understanding these splice variants is key to lung cancer research.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- K-ras is a key oncogene implicated in various cancers.
- K-ras exists as two main splice variants, K-ras 4A and K-ras 4B, with distinct roles.
- The specific contributions of endogenous K-ras 4A and K-ras 4B to lung tumorigenesis remain incompletely understood.
Purpose of the Study:
- To elucidate the distinct roles of endogenous K-ras 4A and K-ras 4B splice variants in lung tumorigenesis.
- To investigate how these splice variants influence tumor initiation, growth, and associated signaling pathways.
Main Methods:
- Murine lung carcinogenesis induced by N-methyl-N-nitrosourea (MNU) to create a common K-ras mutation (G12D).
- Utilized genetically modified mice with specific deletions or alterations in K-ras splice variants (K-ras(tmDelta4A/-), K-ras(+/-), K-ras(tmDelta4A/tmDelta4A)).
- Analyzed tumor number, size, pathology, and expression of key signaling proteins (phospho-Erk1/2, phospho-Akt).
Main Results:
- Mutationally activated K-ras 4B alone initiated lung tumorigenesis and activated MAPK and PI3-K/Akt pathways.
- Co-expression of mutationally activated K-ras 4A with K-ras 4B significantly increased tumor number and size.
- Wild-type K-ras 4B demonstrably reduced tumor number and size, irrespective of K-ras 4A expression.
Conclusions:
- Mutationally activated K-ras 4B is sufficient for lung tumor initiation and pathway activation.
- Mutationally activated K-ras 4A acts as a potent promoter of lung tumor formation and growth.
- Wild-type K-ras 4B possesses tumor-suppressive properties in the context of K-ras-driven lung carcinogenesis.
More Related Videos
07:08Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...